Recording-Breaking Year for Commercialization: Bringing IP to Market
Aug 06, 2025

CardioTag, a device developed in Omer Inan’s lab, is now FDA-cleared and on the path to market through Cardiosense. Georgia Tech supported the technology’s transition from research to real-world application.
Recording-Breaking Year for Commercialization: Bringing IP to Market
Before a company can go to market and see success, research must transition into a real-world application. Meaningful translation of research happens when a startup goes to market and sees success. And the first step at Georgia Tech is for researchers to disclose their inventions to the Office of Technology Licensing (OTL). As the 2025 fiscal year comes to a close, OTL is celebrating a record-breaking year that solidifies Georgia Tech’s position as a national leader in tech transfer and research commercialization.
With industries across the country turning to Georgia Tech for innovative solutions, the numbers tell a powerful story:
- 464 new invention disclosures — a 31% increase over the previous year and the highest ever recorded by the Institute.
- 70 invention disclosures for the Georgia Tech Research Institute, marking a 70% increase year over year.
- A 210% increase in technologies licensed, and 140% in total licenses executed, reflecting unprecedented industry interest.
- 124 U.S. patents were issued, representing a 20% increase compared to the prior year.
These numbers are the highest ever recorded, which highlights the growing success of research and innovation happening at Georgia Tech.
“This record year of growth isn’t just a win for Georgia Tech — it’s a win for industry and proves that Georgia Tech is a leader in research that is transformative and meaningful,” said Mary Albertson, director of the Office of Licensing Technology at Georgia Tech. “Our office is at the forefront of guiding and managing the licensing process, so that we can grow invention disclosures and move the products out into the marketplace.”
OTL is a vital part of Georgia Tech’s Office of Commercialization, which drives the transition of the Institute’s leading-edge research into real-world applications. The Office aims to accelerate innovation and improve the human condition, solidifying Georgia Tech’s leadership in technology and entrepreneurship. Made up of four units, it empowers students and faculty to launch startups, manage intellectual property, and transform research ideas into positive societal impact.
“The Office of Commercialization is fully mobilized as a national hub to support Georgia Tech faculty, staff, and students for innovation, creativity, and entrepreneurship, and is stronger than ever. This record year for the Office of Technology Licensing proves that,” said Raghupathy "Siva" Sivakumar, vice president of Commercialization and chief commercialization officer at Georgia Tech. “With this complete ecosystem of the four units, we can support ideas and ventures from inception to launch and beyond at any stage of commercialization or ideation.”
Omer Inan, a researcher, faculty member, and entrepreneur at Georgia Tech, has launched multiple companies with the support of the Institute’s commercialization resources. Cardiosense is a medical AI company that leverages sensors to provide better management of cardiovascular disease. Having just achieved FDA 510(k) clearance, its latest device — CardioTag — is the first multimodal, wearable sensor that simultaneously captures three cardio signals to provide noninvasive solutions for heart health.
“One of the main reasons I joined Georgia Tech as a faculty member was to play a role in leading the development and launch of new technologies, moving all the way from concept through commercialization,” said Inan. “Great ideas are only beneficial to society when they impact people’s lives through the products that result from them; I am thankful for our commercialization ecosystem that helps us as inventors at each stage of that process, from patent filing to licensing.”
The four units within Georgia Tech Commercialization:
- Technology Licensing: Manages intellectual property, facilitating the transfer of groundbreaking inventions from the lab to the marketplace.
- CREATE-X: Empowers students and faculty to launch their startups through guidance, funding, and resources, fostering a culture of innovation and entrepreneurship.
- Quadrant-i: The newest addition to the Office of Commercialization helps faculty, researchers, and students translate their research into startups.
- VentureLab : Provides comprehensive commercialization support, transforming Georgia Tech's research into viable businesses.
OTL is pivotal in helping to coordinate work within the Office of Commercialization and advancing Atlanta’s entrepreneurial ecosystem. Through OTL’s role in assisting companies around the world in exploring the groundbreaking work being done at Georgia Tech, it collaborates with researchers to move technologies and data out by licensing Georgia Tech technologies. The role of OTL is critical in helping researchers establish licensing agreements that will bring important Georgia Tech innovations into the marketplace.
To learn more about the licensing process, visit licensing.research.gatech.edu.